Vivos Therapeutics VVOS
NASDAQ VVOS
$0.10 +0.00 (+2.24%)
At close: Nov 9, 2026 · 4:00 PM EST

Vivos Therapeutics (VVOS) Return on Sales [ROS] (2020 - 2026)

Updated

Vivos Therapeutics' Return on Sales [ROS] came in at -93.63% for Q2 2026, up 33.72 percentage points from -127.36% a year earlier and up 35.04 percentage points from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vivos Therapeutics reported Return on Sales [ROS] of -107.92%, down 9.03 percentage points year-over-year; for FY2025, it came in at -114.05%, down 39.73 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of -21.90 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -74.32% in FY2024 (+51.00 pp), -125.32% in FY2023 (+30.89 pp), -156.21% in FY2022 (-35.50 pp) and -120.71% in FY2021 (-28.56 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -182.19% (Q1 2022) to -47.76% (Q2 2024).
  • Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of -7.88 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2024 (a gain of 85.29 percentage points), and the weakest in Q4 2025 (a drop of 91.01 percentage points).
  • Business Quant data shows VVOS's Return on Sales [ROS] at -128.67% (Q1 2026), -166.89% (Q4 2025) and -69.79% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn 10.44%
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn 19.44%
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn 18.08%
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn 15.86%
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn 17.44%
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn 13.31%
10 Vivos Therapeutics 1.68 Mn -7.36 Mn 2.95 Mn -93.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -93.63%
Mar 31, 2026 -128.67%
Dec 31, 2025 -166.89%
Sep 30, 2025 -69.79%
Jun 30, 2025 -127.36%
Mar 31, 2025 -129.91%
Dec 31, 2024 -75.88%
Sep 30, 2024 -68.52%
Jun 30, 2024 -47.76%
Mar 31, 2024 -110.70%
Dec 31, 2023 -127.25%
Sep 30, 2023 -110.27%
Jun 30, 2023 -133.05%
Mar 31, 2023 -129.76%
Dec 31, 2022 -153.49%
Sep 30, 2022 -127.34%
Jun 30, 2022 -166.44%
Mar 31, 2022 -182.19%
Dec 31, 2021 -168.66%
Sep 30, 2021 -121.05%
API Access

Vivos Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VVOS&period=max&api_key=YOUR_API_KEY